Cynata Therapeutics Limited (ASX:CYP)
Managing Director and CEO Dr Ross Macdonald presents at the ASX Investor Series in Sydney.
The regenerative medicine company’s presentation is titled, “A Next Generation Stem Cell Company”.
Dr Macdonald outlines Cynata’s key facts and focus and introduces regenerative medicine and the group’s Cymerus™ technology.
The presentation covers Cynata’s stem cell manufacturing breakthrough and manufacturing issues attracting global attention.
Looking at the industry Dr Macdonald provides a comparison to stem cell company market valuations and discusses the company’s path to revenue.
Dr Macdonald also lists Cynata’s value catalysts and proposition including recent achievements and following priorities.